A new study published in Psychological Medicine shows evidence that legalizing cannabis does not increase substance use disorders or use of other illicit drugs and therefore is not considered a gateway drug.
In fact, cannabis may actually reduce alcohol-related problems said researchers from the University of Colorado Boulder, reported a news local outlet.
The study found no link between cannabis legalization and increases in cognitive, psychological, social, relationship or financial problems.
“We really didn’t find any support for a lot of the harms people worry about with legalization,” said lead author Stephanie Zellers, who began the research as a graduate student at CU Boulder’s Institute for Behavioral Genetics (IBG). “From a public health perspective, these results are reassuring.”
Researchers took data from the Institute for Behavioral Genetics and the Minnesota Center for Twin Family Research to study 4,000 twins (40% in a state with legal recreational weed, Colorado, and 60% in a state without legal cannabis like Minnesota), per Fox 31 news outlet.
Regarding the study's methods, the researchers used "a longitudinal, co-twin control design in 4043 twins, first assessed in adolescence and now age 24–49, currently residing in states with different cannabis policies (40% resided in a recreationally legal state).”
Legalization Of Recreational Cannabis Decreases Alcohol Use Disorder
Researchers found that the twins living in a recreational state used cannabis on average more often and had fewer alcohol use disorder (AUD) symptoms than their co-twins living in a non-recreational state.
“This co-twin design automatically controls for a wide range of variables, including age, social background, early home life, and even genetic inheritance” that can influence health outcomes, said John Hewitt, professor of psychology and neuroscience at CU Boulder. “If the association holds up, it provides strong evidence that the environment, in this case, legalization, is having an impact.”
Researchers concluded that the association between adult use legalization with increased cannabis use and decreased AUD symptoms was not linked with other maladaptations. However, "future research may investigate causal links between cannabis consumption and outcomes," they concluded.
The Benzinga Cannabis Capital Conference Is Back!
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A start, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo: Courtesy Of Engin Akyurt and Washarapol D BinYo Jundang by Pexels and Linkedin Edited By Benzinga
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
BENZINGA CANNABIS CONFERENCE
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us April 11-12, 2023 at Fontainebleau Miami Beach in sunny Florida.